<p>Section 1. Introduction<br>1. Drug Repositioning: New Opportunities for Older Drugs<br>2. Computational Drug Design Methods – Current and Future Perspectives</p> <p>Section 2. Theoretical Background and Methodologies<br>3. In Silico Drug Design Methods for Drug Repurposing<br>4. Computational Drug Repurposing for Neurodegenerative Diseases<br>5. Repurposed molecules: A New Hope in Tackling Neglected Infectious Diseases<br>6. Molecular Docking: A Structure-Based Approach for Drug Repurposing<br>7. Data Science Driven Drug Repurposing for Metabolic Disorders<br>8. Data-driven Systems Level Approaches for Drug Repurposing: Combating Drug Resistance in Priority Pathogens<br>9. In Silico Repurposing of Cell Cycle Modulators for Cancer Treatment<br>10. Proteochemometric Modeling for Drug Repositioning<br>11. Drug Repurposing from Transcriptome Data: Methods and Applications<br>12. Omics-driven Knowledge Based Discovery of Anthelmintic Targets and Drugs<br>13. Analysis of Chemical Spaces: Implications for Drug Repurposing</p> <p>Section 3. Examples and Case Studies<br>14. Drug Repurposing in Search of Anti-Infectives: Need of the Hour in the Multi-Drug Resistance Era!<br>15. Application of In Silico Drug Repurposing in Infectious Diseases<br>16. In Silico Modeling of FDA-approved Drugs for Discovery of Anti-candida Agents: A Drug Repurposing Approach <br>17. In silico Modeling of FDA-approved Drugs for Discovery of Anticancer Agents: A Drug Repurposing Approach<br>18. Tackling Lung Cancer Drug Resistance using Integrated Drug Repurposing Strategy <br>19. In Silico Modeling of FDA-approved Drugs for Discovery of Anti-cancer Agents: A Drug Repurposing Approach <br>20. Drug Repurposing by Connectivity Mapping and Structural Modeling<br>21. In Silico Modeling of FDA-approved Drugs for Discovery of Therapies Against Neglected Diseases: A Drug Repurposing Approach<br>22. Ascorbic Acid is a Potential Inhibitor of Collagenases – In Silico and In Vitro Biological Studies <br>23. Bioinformatic Approaches for Repurposing and Repositioning Antibiotics, Antiprotozoals and<br>Antivirals </p> <p>Section 4. Tools and databases<br>24. In Silico Databases and Tools for Drug Repurposing <br>25. An Overview of Computational Methods, Tools, Servers and Databases for Drug Repurposing<br>26. In silico Drug Repurposing for MDR Bacteria: Opportunities and Challenges<br>27. Drug Repositioning Strategies to Explore New Candidates Treating Prostate Cancer<br>28. PDID: Database of Experimental and Putative Drug Targets in Human Proteome</p>
